Posts Tagged ‘shires’

FDA Grants Priority Review for Shire’s velaglucerase alfa for Type 1 Gaucher Disease- FDA Issued Action Date of February 28, 2010 Under the Prescription Drug User Free Act (PDUFA)PR NewswireCAMBRIDGE, Massachusetts, November 4 CAMBRIDGE, Massachusetts, November 4 /PRNewswire/ — Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has granted Priority Review ... Full story